<DOC>
	<DOCNO>NCT00734578</DOCNO>
	<brief_summary>The purpose study assess efficacy safety SPD503 subject ADHD co-administered psychostimulants child adolescent age 6-17 year diagnosis ADHD sub-optimal , partial response stimulant .</brief_summary>
	<brief_title>Efficacy Safety SPD503 Combination With Psychostimulants</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Healthy subject ADHD currently take stable dose psychostimulant least 4 week Aged 617 year suboptimal Partial response stimulant Subjects must &lt; 95th percentile BMI weight &gt; = 55lbs &lt; = 176lbs</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>